Join
Live feed
·
PRReleasevia Quantisnow
Ocuphire Pharma Inc. logo

Ocuphire Pharma to Highlight APX3330 for Diabetic Retinopathy at Two Scientific Meetings in July

ByQuantisnow·Wall Street's wire, on your screen.
OCUP· Ocuphire Pharma Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track OCUP (Ocuphire Pharma Inc.) and more on Quantisnow.